Analytical Data
-
Gene name
CTDSPL
- Application
-
Alternative Names
CTDSPL；C3orf8；NIF1；NIFL;CTD small phosphatase-like Protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O15194-2
-
Expression Region
82-265aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMKYLLP EVTVLDYGKK CVVIDLDETL VHSSFKPISN ADFIVPVEID GTIHQVYVLK RPHVDEFLQR MGQLFECVLF TASLAKYADP VADLLDRWGV FRARLFRESC VFHRGNYVKD LSRLGRELSK VIIVDNSPAS YIFHPENAVP VQSWFDDMTD TELLDLIPFF EGLSREDDVY SMLHRLCNR
-
Molecular Weight
24 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CTDSPL (C-Terminal Domain Src-Interaction Protein Like) is a protein implicated in various cellular processes, including signal transduction and cytoskeletal organization. Its role in modulating cellular responses to stimuli has garnered significant interest in the field of molecular biology. Recent studies have highlighted the potential of CTDSPL in cancer research, as alterations in its expression levels have been observed in several cancer types. The protein is believed to interact with different signaling pathways, influencing cell proliferation and migration. Moreover, CTDSPL's involvement in regulating apoptosis and cellular differentiation suggests that it could serve as a potential biomarker for tumor progression or a therapeutic target. Given the complex nature of its interactions and functions, researchers have initiated efforts to reconstruct CTDSPL in recombinant form. This approach aims to produce the protein in a laboratory setting, enabling detailed studies of its structure and function. The recombinant CTDSPL will facilitate the exploration of its binding partners, elucidate its role in signaling pathways, and allow for the screening of small molecules that could modulate its activity. These investigations are essential to understand the intricate mechanisms by which CTDSPL influences cellular behavior, potentially paving the way for innovative cancer therapies and diagnostic tools.
